DK35589A - Stabil blanding indeholdende oxidationsfoelsomme forbindelser, fremgangsmaade til fremstilling heraf og anvendelse af en kombination af stoffer til stabilisering af oxidationsfoelsomme stoffer - Google Patents
Stabil blanding indeholdende oxidationsfoelsomme forbindelser, fremgangsmaade til fremstilling heraf og anvendelse af en kombination af stoffer til stabilisering af oxidationsfoelsomme stofferInfo
- Publication number
- DK35589A DK35589A DK035589A DK35589A DK35589A DK 35589 A DK35589 A DK 35589A DK 035589 A DK035589 A DK 035589A DK 35589 A DK35589 A DK 35589A DK 35589 A DK35589 A DK 35589A
- Authority
- DK
- Denmark
- Prior art keywords
- substances
- oxidation sensitive
- procedures
- preparing
- combination
- Prior art date
Links
- 230000003647 oxidation Effects 0.000 title 2
- 238000007254 oxidation reaction Methods 0.000 title 2
- 239000000126 substance Substances 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000000087 stabilizing effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Medicinal Preparation (AREA)
- Fats And Perfumes (AREA)
- Edible Oils And Fats (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1723288 | 1988-01-29 | ||
| JP1723288 | 1988-01-29 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK35589D0 DK35589D0 (da) | 1989-01-27 |
| DK35589A true DK35589A (da) | 1989-07-30 |
| DK174663B1 DK174663B1 (da) | 2003-08-18 |
Family
ID=11938201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198900355A DK174663B1 (da) | 1988-01-29 | 1989-01-27 | Stabil blanding indeholdende oxidationsfølsomme forbindelser, fremgangsmåde til fremstilling heraf og anvendelse af en kombination af stoffer til stabilisering af oxidationsfølsomme forbindelser |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4929774A (da) |
| EP (1) | EP0326026B1 (da) |
| KR (1) | KR890011974A (da) |
| CN (1) | CN1023229C (da) |
| CA (1) | CA1331136C (da) |
| DE (1) | DE58901641D1 (da) |
| DK (1) | DK174663B1 (da) |
| IL (1) | IL88961A (da) |
| IN (1) | IN171845B (da) |
| SU (1) | SU1639425A3 (da) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2610626B1 (fr) * | 1987-02-09 | 1989-05-19 | Oreal | Nouveau systeme anti-oxydant a base d'un ester d'ascorbyle stabilise, contenant en association au moins un agent complexant et au moins un thiol, et compositions contenant un tel systeme anti-oxydant |
| JPH02124894A (ja) * | 1988-11-01 | 1990-05-14 | Sanwa Kagaku Kenkyusho Co Ltd | フィチン酸安定化組成物 |
| US5180747A (en) * | 1989-02-28 | 1993-01-19 | Nisshin Flour Milling Co., Ltd. | Stabilized fat-soluble vitamin compositions |
| US5290605A (en) * | 1989-06-29 | 1994-03-01 | Niva Shapira | Sun-exposure nutritional supporting composition |
| KR930006431B1 (ko) * | 1990-10-11 | 1993-07-16 | 재단법인 한국화학연구소 | 약물의 미세캡슐화 방법 |
| KR100295030B1 (ko) * | 1992-07-13 | 2001-09-17 | 겜마 아키라 | 피부외용조성물 |
| US5270063A (en) * | 1992-08-03 | 1993-12-14 | Kellogg Company | Ready-to-eat cereal products enriched with beta-carotene |
| FR2703263B1 (fr) * | 1993-03-31 | 1995-05-19 | Rhone Poulenc Nutrition Animal | Procédé de préparation de sphérules de principes actifs. |
| IL110139A0 (en) * | 1993-06-28 | 1994-10-07 | Howard Foundation | Pharmaceutically-active antioxidants |
| JPH07203950A (ja) * | 1994-01-26 | 1995-08-08 | Kanegafuchi Chem Ind Co Ltd | 被覆されたファフィア・ロドチーマ酵母及びその造粒物 |
| AUPM677594A0 (en) * | 1994-07-12 | 1994-08-04 | Daratech Pty Ltd | Preservation of exposed underground plant structures |
| MX9707584A (es) * | 1995-04-07 | 1998-02-28 | Abbott Lab | Complementos de calcio y bebidas que contienen calcio y que comprenden vitamina d. |
| US5817351A (en) * | 1995-04-07 | 1998-10-06 | Abbott Laboratories | Calcium fortified low pH beverage |
| DE19518845A1 (de) * | 1995-05-23 | 1996-11-28 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Phytinsäure |
| US5827904A (en) * | 1996-09-27 | 1998-10-27 | Hahn; David | Medical implant composition |
| JP2002513411A (ja) | 1997-04-04 | 2002-05-08 | ヘンケル コーポレーション | 高いバイオアベイラビリティを有するルテインエステル |
| US6007856A (en) * | 1997-08-08 | 1999-12-28 | The Procter & Gamble Company | Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid |
| US20020068090A1 (en) * | 1999-02-03 | 2002-06-06 | Bell Steve J. D. | Calcium phosphate particles as mucosal adjuvants |
| US20040258763A1 (en) * | 1999-02-03 | 2004-12-23 | Bell Steve J.D. | Methods of manufacture and use of calcium phosphate particles containing allergens |
| WO2000046147A2 (en) | 1999-02-03 | 2000-08-10 | Biosante Pharmaceuticals, Inc. | Therapeutic calcium phosphate particles and methods of manufacture and use |
| US20020054914A1 (en) * | 1999-02-03 | 2002-05-09 | Tulin Morcol | Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein |
| US6328995B1 (en) * | 1999-09-24 | 2001-12-11 | Basf Aktiengesellschaft | Stable vitamin and/or carotenoid products in powder form and process for their production |
| EP1355877A1 (en) * | 2001-01-30 | 2003-10-29 | Sabinsa Corporation | Process of obtaining compositions of stable lutein and lutein derivatives |
| US20060062855A1 (en) * | 2001-02-27 | 2006-03-23 | Bell Steve J D | Therapeutic calcium phosphate particles for use in inhibiting expression of a gene |
| US20030185892A1 (en) * | 2001-08-17 | 2003-10-02 | Bell Steve J. D. | Intraocular delivery compositions and methods |
| DE10300325A1 (de) | 2003-01-09 | 2004-07-22 | Hexal Ag | Granulat mit öliger Substanz, Herstellungsverfahren und Tablette |
| WO2004066750A1 (en) | 2003-01-31 | 2004-08-12 | Dsm Ip Assets B.V. | Novel compositions comprising carotenoids |
| DE10311585A1 (de) | 2003-03-14 | 2004-09-23 | Basf Ag | Wirkstoffhaltige Adsorbate |
| DE10325989A1 (de) * | 2003-06-07 | 2005-01-05 | Glatt Gmbh | Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung |
| US7446101B1 (en) * | 2003-12-12 | 2008-11-04 | Bioactives, Llc | Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems |
| US9247765B2 (en) * | 2004-01-14 | 2016-02-02 | Omniactive Health Technologies Limited | Stable beadlets of lipophilic nutrients |
| CA2560613C (en) | 2004-03-22 | 2015-11-24 | Solvay Pharmaceuticals Gmbh | Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
| US7351424B2 (en) * | 2004-07-22 | 2008-04-01 | Bio Lut S.A. De C.V. | Enhanced purity trans-lutein-ester compositions and methods of making same |
| AU2005265617B2 (en) * | 2004-07-30 | 2010-09-30 | Wakunaga Pharmaceutical Co., Ltd. | Composition for capsule film, capsule film, and capsule made with the same |
| CA2586035A1 (en) * | 2004-11-01 | 2006-05-11 | Biosante Pharmaceuticals, Inc. | Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use |
| RU2290173C2 (ru) * | 2005-04-04 | 2006-12-27 | Открытое акционерное общество "Научно-исследовательский институт технологий медицинской промышленности" (ОАО"НИИ ТМП") | Способ получения стабильных сухих порошков жирорастворимых витаминов или каротиноидов |
| HUE031042T2 (en) | 2005-07-29 | 2017-06-28 | Abbott Laboratories Gmbh | Methods for producing pancreatin powder with low viral content |
| US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
| US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
| US20070065487A1 (en) * | 2005-09-21 | 2007-03-22 | Bio Lut S.A. De C.V. | Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof |
| US7767238B2 (en) * | 2005-11-04 | 2010-08-03 | Pepsico, Inc. | Beverage composition and method of preventing degradation of vitamins in beverages |
| US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
| US20090130063A1 (en) * | 2007-11-15 | 2009-05-21 | Solvay Pharmaceuticals Gmbh | Process for separating and determining the viral load in a pancreatin sample |
| ES2969807T3 (es) * | 2016-03-24 | 2024-05-22 | Basf Se | Preparados de principios activos de múltiples fases |
| WO2024173923A2 (en) * | 2023-02-17 | 2024-08-22 | Solugen, Inc. | Feed compositions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3135329A1 (de) * | 1981-09-05 | 1983-03-24 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen |
-
1989
- 1989-01-16 IL IL88961A patent/IL88961A/xx not_active IP Right Cessation
- 1989-01-18 IN IN42/MAS/89A patent/IN171845B/en unknown
- 1989-01-20 EP EP89100908A patent/EP0326026B1/de not_active Expired - Lifetime
- 1989-01-20 DE DE8989100908T patent/DE58901641D1/de not_active Expired - Lifetime
- 1989-01-27 SU SU894613322A patent/SU1639425A3/ru active
- 1989-01-27 DK DK198900355A patent/DK174663B1/da not_active IP Right Cessation
- 1989-01-27 CN CN89100550A patent/CN1023229C/zh not_active Expired - Fee Related
- 1989-01-27 CA CA000589338A patent/CA1331136C/en not_active Expired - Fee Related
- 1989-01-27 US US07/302,611 patent/US4929774A/en not_active Expired - Lifetime
- 1989-01-28 KR KR1019890000932A patent/KR890011974A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| IN171845B (da) | 1993-01-23 |
| IL88961A (en) | 1992-07-15 |
| CA1331136C (en) | 1994-08-02 |
| DK174663B1 (da) | 2003-08-18 |
| KR890011974A (ko) | 1989-08-23 |
| EP0326026A3 (en) | 1990-11-14 |
| CN1023229C (zh) | 1993-12-22 |
| CN1036220A (zh) | 1989-10-11 |
| DK35589D0 (da) | 1989-01-27 |
| SU1639425A3 (ru) | 1991-03-30 |
| IL88961A0 (en) | 1989-08-15 |
| DE58901641D1 (de) | 1992-07-23 |
| EP0326026A2 (de) | 1989-08-02 |
| EP0326026B1 (de) | 1992-06-17 |
| US4929774A (en) | 1990-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK35589A (da) | Stabil blanding indeholdende oxidationsfoelsomme forbindelser, fremgangsmaade til fremstilling heraf og anvendelse af en kombination af stoffer til stabilisering af oxidationsfoelsomme stoffer | |
| DK162518C (da) | Fremgangsmaade til fremstilling af en stabil modifikation af torasemid, samt et farmaceutisk praeparat indeholdende denne | |
| DK101288D0 (da) | Lagdelt chalcogenidmateriale, katalysator indeholdende dette samt fremgangsmaade til fremstilling af dette | |
| DK272587D0 (da) | Stabiliserede praeparater, der indeholder flere vitaminer og sporgrundstoffer | |
| DK340785A (da) | Quinonderivater, fremgangsmaade til fremstilling af dem og farmaceutisk praeparat indeholdende dem | |
| DK183589A (da) | Farmaceutisk middel indeholdende en 12-leddet macrolid-forbindelse og fremgangsmaade til fremstilling heraf | |
| NO894999L (no) | Antiseptiske blandinger inneholdende heksahydro-5-pyrimidinaminforbindelser og thymol og fremgangsmaater for fremstilling derav. | |
| DK106989D0 (da) | Isoindolinonderivat, fremgangsmaade til fremstilling af dette, og laegemiddel indeholdende dette | |
| DK4189A (da) | Oxadiazolforbindelse, farmaceutisk praeparat indeholdende og fremgangsmaade til fremstilling af forbindelsen | |
| DK127588A (da) | Beta-aminoethylsubstituerede phenylforbindelser, farmaceutiske praeparater indeholdende samme og fremgangsmaader til fremstilling af saadanne forbindelser | |
| IL57847A0 (en) | Adducts of k vitaminic compounds and stabilizing vitamins,preparation thereof and stabilized adducts thus provided | |
| DK218985A (da) | Aminocyklopentylaetere, farmaceutiske praeparater indeholdende dem og fremgangsmaade til fremstilling af dem | |
| DK565288D0 (da) | Fremgangsmaade til fremstilling af triglycerider, anvendelse af saadanne triglycerider og en emulsion, der indeholder saadanne triglycerider | |
| DK166088C (da) | 2'-deoxy-5-fluoruridinderivater, fremgangsmaade til fremstilling deraf, anticancermidler indeholdende saadanne forbindelser og anvendelse af saadanne forbindelser til fremstilling af anticancermidler | |
| DK36588A (da) | 5-oxy derivater af tetrahydrofuran, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende saadanne forbindelser | |
| DK187989D0 (da) | Substituerede propanaminer, fremgangsmaade til fremstilling heraf og laegemidler indeholdende saadanne forbindelser | |
| DK262286A (da) | Fenantrenderivater, fremgangsmaade til fremstilling deraf og fungicide praeparater indeholdende saadanne forbindelser | |
| DK81287D0 (da) | 2-cyanobenzimidazolderivater, fremgangsmaade til fremstilling deraf og kombinations-fungicidpraeparater indeholdende saadanne forbindelser | |
| DK597184D0 (da) | Substituerede spiro-pyridinderivater, farmaceutiske praeparater indeholdende dem og fremgangsmaade til fremstilling af saadanne forbindelser | |
| DK123488D0 (da) | 2-oxa-isocephemforbindelser, praeparater indeholdende dem, og fremgangsmaader til fremstilling af dem | |
| DK525187A (da) | Imidazooe4,5-baapyridinon-2-derivater, fremgangsmaade til fremstilling af og laegemidler indeholdende saadanne derivater | |
| DK653589D0 (da) | Fremgangsmaade til fremstilling af reaktionsproduktblanding omfattende di-substituerede-imidazolinforbindelser og toejbloedgoeringsmiddel omfattende samme | |
| DK144877A (da) | Fremgangsmade til fremstilling af en stabil neutral vandig oplosning indeholdende rent theophylin en saledes fremstillet oplosning og dennes anvendelse | |
| DK575387D0 (da) | Hydrofluorenderivater, fremgangsmaade til fremstilling deraf og praeparater indeholdende saadanne forbindelser | |
| DK561787A (da) | Thiadiazol-derivat, fremgangsmaade til fremstilling af dette, farmaceutisk praeparat indeholdende dette samt anvendelse af dette til fremstilling af et laegemiddel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |